PO-86 Can we improve the prediction of the rate of complications following pulmonary embolism diagnosis in cancer patients? Prospective validation of the epiphany INDEX: the PERSEO study
Manuel Sánchez Cánovas(Pontificia Universidad Católica de Chile), Eva Martínez de Castro(Marqués de Valdecilla University Hospital), Ignacio Escobar(Hospital Universitario 12 De Octubre), Roberto Morales Giménez(Hospital General Universitario de Elche), Michelle Sarmiento, David Fernández Garay(Complejo Hospitalario de Jaén), Cristina Sánchez Cendra(Hospital Universitario de Guadalajara), V. Arrazubi Arrula(Complejo Hospitalario de Navarra), Diana Moreno Muñoz(Hospital Universitario Fundación Alcorcón), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Irma de la Haba Vacas(Institut Català d'Oncologia), Eva Coma Salvans(Institut Català d'Oncologia), P. Sampedro Domarco, Ágatha Martín, Ánxela Vidal, María José Ortiz, David Gómez(Complejo Hospitalario de Navarra), L. Ortega Morán, P. Jiménez Fonseca, Marina Peña(Hospital Universitario Son Espases), Mónica Cejuela Solís(Hospital Universitario Insular de Gran Canaria), D. Elia
Cited by 0
Related Papers
The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab
|The Oncologist|2011|129
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60